For CROs and sponsor study teams

Study Startup Software for CROs and Sponsors

TrialConnx gives CRO and sponsor startup teams one live status across every site, so you see who is stuck and move activation without another status meeting.

What changes

Open the status. Don't rebuild it.

You already run startup across sites. TrialConnx replaces the chase with one view the sponsor call can start from.

Without a shared view
With TrialConnx
Status arrives. Then you sort it.
Status is the view. You open it.
Status comes from weekly emails and call notes
Every site's stage, owner, and aging is in one view
Comparing sites means a manual spreadsheet
The same slow stage at several sites shows up in one view
Activation slips surface on the Friday call
Aging is visible before the status meeting
Updates for the sponsor are pulled together from many places
That update starts from the same view

What you stop doing by hand

Every site. One study, or all of them.

Filter by study, sponsor, aging, or stage. You see who needs attention before the sponsor call.

One study, many sites

See stage, owner, and aging without rebuilding the summary.

Stages, left to right: Intake, Feasibility, Budget, Contract, IRB, Activation.

Spot activation risk

See how long each stage is taking, so you spot sites that need attention before the next status call.

The same slow stage at several sites

When several sites are stuck at the same stage, you see it once instead of chasing each site on its own.

The next conversation goes to the owner

You see who has the next step: site, sponsor, CRO, PI or department, contracts, or IRB. TrialConnx shows who has it. It does not do the step for you.

Working with sites

You see the study. Sites keep their tools.

Sponsors and CROs use TrialConnx while sites keep their process. You share stage, owner, and aging.

The same stages on every study

TodayStatus arrives by email, call, and PDF. Every study is tracked a different way.
With TrialConnxA site-by-site view across studies, with the same stages each time.

Who has the next step

TodayFinding who holds the document takes another email chain.
With TrialConnxYou can see who has it: site, sponsor, CRO, or IRB.

The portfolio

Every site on a study. Every study you are opening.

TrialConnx is the portfolio view of activation. A study manager sees progress by site, by country, and by CRA, the monitors who oversee sites, then the rest of the book, without starting a new spreadsheet for each.

One study, all of its sites

Each site shows its stage, its owner, and what is bottlenecked. Compare sites in one country, or across countries, without calling them one by one.

The full book of studies

The same stages run across the studies in startup. Open the portfolio by study, by sponsor, by country, by CRA, by stage, or by how long work has been sitting.

What is stuck

See the hold-up, and who has it

TrialConnx shows the stage, how long it has been sitting, and the person or group with the next step. That is how a study manager finds the sites that need a call.

The stage and the wait

Aging and cycle time sit on the startup view, so a slow stage is visible before the status meeting.

Who has the next step

Site, sponsor, CRO, PI or department, contracts, or IRB. The hold-up has a name, so the next conversation goes there.

What leadership opens

Aging, bottlenecks, cycle time, how close sites are to opening, and the health of the portfolio. No one builds a slide first.

Your CTMS

TrialConnx integrates with the CTMS you already run

It sits with the CTMS sponsors and CROs already run, including OnCore, Veeva, Medidata, WCG, and RealTime. TrialConnx keeps that system up to date as each site opens, so teams do not enter the same study and site details twice. When a site is ready to open, the startup record moves into that system.

Study and site records

Study number, sponsor, PI, and the sites on the study move with the record.

Activation status

The point a site is ready to open is part of what crosses over.

Startup milestones

Approved budget, contract status, and IRB approval travel with the study, tied to those sites.

How the handoff is set up: Study startup vs CTMS.

FAQ

Questions sponsor and CRO teams ask

How do we see every site on a study without a status spreadsheet?

Open the study in TrialConnx. Each site shows its stage, its owner, and what is bottlenecked. The same portfolio covers the other studies you are opening.

How do we find the sites that are stuck?

Look at the stage and how long it has been sitting. TrialConnx also names who has the next step: the site, your team, the sponsor, contracts, or the IRB.

What does leadership see without a status deck?

Aging, bottlenecks, cycle time, how close sites are to opening, and the health of the portfolio. Leaders open that view. They do not wait for a report to be built.

What flows into the CTMS we already use?

TrialConnx integrates with it and keeps it up to date as each site opens, so teams do not enter the same study and site details twice. Study and site records, activation status, and the startup milestones (approved budget, contract status, and IRB approval) move across when a site is ready to open.

Do study managers still chase sites for a weekly update?

The portfolio is the update. A stall on more than one site shows up there, so the weekly chase is not a separate spreadsheet.

Can we look at one sponsor's studies together?

Yes. Open the portfolio by sponsor, by study, by stage, or by how long work has been sitting.

Can we compare sites across countries?

Yes. Open the portfolio by country. You see which sites are moving and which are stuck, on one study or across the studies you are opening.

Can we see progress by CRA?

Yes. Group the sites by the CRA who covers them. Their stages sit together, so you can see who needs a call without building another sheet.

Bring one study and the sites on it.

We will show the portfolio, the sites that are stuck, and what moves into your CTMS. For the site's own view, see site activation software.